ToMORROW gives dairy producers time-tested, broad-spectrum control against the harmful organisms
that cause mastitis in dry cows.
ToMORROW has been an effective extended therapy treatment for more than 25 years, and
studies have shown no change in the development of bacterial resistance.1,2
ToMORROW has been shown by extensive clinical studies to be efficacious in the treatment of
mastitis in dry cows, when caused by Streptococcus agalactiae and Staphylococcus aureus
including penicillin-resistant strains.
ToMORROW is formulated with cephapirin benzathine to provide broad spectrum and long-acting
therapy that dry cows need.
Unique Opti-Sert tip helps prevent pushing harmful surface bacteria into the teat canal
Reduces the risk of new infections
Allows antibiotic contact with teat-canal infections
Provides the option of partial or full insertion with an exclusive, easy-to-use protective cap.
Infuse a 10 mL syringe (300 mg cephapirin activity per syringe) once each quarter has been completely
TOMORROW should be administered with caution to subjects which have demonstrated some form of
allergy, particularly to penicillin. Such reactions are rare; however, should they occur, consult your
For use in dry cows only.
Not to be used within 30 days of calving.
Milk from treated cows must not be used for food during the first 72 hours after calving.
Any animal infused with this product must not be slaughtered for food until 42 days after the